Welcome to DM Consulting
We are full-service boutique consulting firm specializing in providing customized solutions for biotech start-ups in the cell and gene, antibodies, and diagnostics markets. We are headquartered in CT/MA area and our team of experts within our network have years of experience in business strategy, helping clients streamline their operations, increase revenue, and maximize their growth potential. From raising funds, to strategic sales and marketing planning, building sales teams and expanding GMP capabilities, we offer a wide range of services tailored to meet the unique needs of your business.
Contact us today to schedule a consultation and see how we can help you achieve your goals.
Expert Consulting for Your Business
Strategic Business & Marketing Help
Our team of experts will work with you to develop a solid business strategy that aligns with your goals and objectives. We will assist you identify opportunities for growth; help you raise Series A funding and create a plan to achieve success from marketing to sales. We will help you create a strong brand and develop effective marketing strategies to reach your target audience. We'll help you create engaging content and leverage social media to grow your business.
HR Solutions for Growth
Our HR consultant partner is an All-inclusive trusted ally for expert guidance and tailored solutions that ensure compliance, efficiency, and growth. They will help you create a positive work environment, recruit and retain top talent, and develop performance management systems to ensure your team is working at their best.
Expert Biotech Consulting for Growth
Diana Morales, CEO of DM Consulting, brings 25+ years of experience in bioprocess, cell, and gene therapy sectors. She supports biotech firms, startups, VCs, and academia with strategic insights to foster growth and innovation. Author of "Rise Above The Noise," she dedicated her career to helping clients excel.
Industry Insights
Biotech Updates- March 2026 (By Diana Morales)
471 followersMarch 17, 2026
🚀 Biotech Q1 Pulse- Funding Shifts, FDA Momentum & What’s Ahead for 2026
As we approach the end of Q1 2026 with a sense of renewed direction across biotech measured, data‑driven, and increasingly shaped by new funding models and regulatory clarity. Here’s a concise look at the forces shaping the industry this quarter.
💸 Funding Landscape: Family Offices Take the Lead
The most defining shift of Q1 was
Connect with DM
Visit Us in Person
We value your time. Visit us during our business hours.
DM Biotech Consulting
Our Operating Hours
Open today | 09:00 am – 05:00 pm |
